Lv7
3468 积分 2021-08-15 加入
Reappraisal of prognostic factors in CNS WHO grade 3 oligodendrogliomas IDH-mutant and 1p/19q co-deleted: lessons from the French POLA cohort
14小时前
已完结
The prognostic impact of CDKN2A/B hemizygous deletions in IDH-mutant glioma
15小时前
已完结
NCCN CNS Tumor Guidelines Update for 2024
15小时前
已完结
Inference on the average treatment effect under minimization and other covariate-adaptive randomization methods
3个月前
已关闭
Alteplase for the treatment of midline catheter occlusions: a retrospective, single-cohort descriptive study
3个月前
已完结
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
5个月前
已完结
The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomas
6个月前
已完结
On Errors in Stratified Randomization
6个月前
已完结
IDH1/2 gene hotspot mutations in central nervous system tumours: analysis of 922 Chinese patients
6个月前
已完结
NRG-BN002: Phase I Study of Ipilimumab, Nivolumab, and the Combination in Patients with Newly Diagnosed GBM
7个月前
已完结
皖公网安备34019202002308
